№ lp_2_3_66074
File format: docx
Character count: 3125
File size: 146 KB
Press release announcing research initiatives by the University of Cape Town’s Department of Psychiatry and Mental Health on the genetic and neurobiological basis of schizophrenia in connection with World Mental Health Day 2014.
Date:
10 October 2014
Event:
World Mental Health Day
Theme:
Living with schizophrenia
Institution:
University of Cape Town
Department:
Department of Psychiatry and Mental Health, University of Cape Town
Issued by:
UCT Communication and Marketing Department
Media Liaison Officer:
Kemantha Govender
Location:
Rosebank, South Africa
Research Focus:
Genetic and neuroscientific studies on schizophrenia
Population Studied:
Xhosa population of South Africa
Type of Document:
Press release
Contact Information:
Tel (021) 650 5672; Cell (084) 737 6522; [email protected]
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
Not specified
Region / City:
Cape Town
Topic:
Research access, Ethics, UCT students
Document Type:
Form
Institution:
University of Cape Town (UCT)
Author:
Not specified
Target Audience:
Researchers, UCT students and staff
Period of validity:
1 year from approval
Approval Date:
Not specified
Date of Amendments:
Not specified
Note:
Year
Year:
2026
Region / City:
Cape Town, South Africa
Topic:
Procurement / Purchasing
Document type:
Instructional form
Organization / Institution:
University of Cape Town
Target audience:
UCT staff and vendors
Related policies:
PPP002 – Threshold values for purchasing policy; PUR003 – UCT Purchasing Policy; PUR004 – Tender Policy
Required attachments:
Specifications for requested items
Quotation validity:
30 days
Delivery details:
Provided by UCT department
Year:
2026
Institution:
University of Cape Town (UCT)
Document type:
Clinical research risk assessment form
Purpose:
Sponsorship and no-fault insurance application for research-related bodily injury
Author:
Principal Investigator
Target audience:
Research Governance Officer, Principal Investigator
Protocol title:
Not specified
Protocol number:
Not specified
Funder:
Not specified
Intellectual property owner:
Not specified
Study start date:
Not specified
Study end date:
Not specified
Number of participants:
Not specified
Study sites:
Potentially international
Inclusion of minors:
Conditional
Inclusion of pregnant women:
Conditional
Professional indemnity required:
Conditional
Submission date:
Not specified
Type of document:
Pharmaceutical Benefits Advisory Committee (PBAC) submission and assessment report
Medicine:
Aripiprazole long-acting injectable (AOM)
Dosage forms/strengths:
Powder for injection 300 mg (as monohydrate) with diluent in pre-filled dual-chamber syringe; Powder for injection 400 mg (as monohydrate) with diluent in pre-filled dual-chamber syringe
Brand:
Abilify Maintena
Sponsor:
Lundbeck Australia Pty Ltd
Purpose of submission:
Request for General Schedule Authority Required (STREAMLINED) PBS listing of AOM pre-filled syringe dose form
Indication:
Treatment of schizophrenia
Comparator:
AOM modified release injection vial kit (therapeutic vial kits)
Regulatory status:
TGA registered 7 May 2018 for acute and maintenance treatment of schizophrenia in adults and maintenance treatment of bipolar I disorder (monotherapy)
Previous PBAC consideration:
400 mg AOM PFS recommended July 2018; recommendation rescinded March 2023
Pricing basis:
Cost-minimisation versus AOM vial kit with equivalent pricing (no price premium)
Price levels referenced:
DPMQ, PTP, AEMP (current as of 1 June 2025)
Estimated PBS usage:
400,000 to <500,000 scripts over first six years (Year 1 10,000–<20,000; Year 6 100,457)
Indication listing conditions:
Authority Required (Streamlined); prescriber types include medical practitioners and nurse practitioners; general schedule (Code GE)
Year:
2023
Region / city:
Rohtak, Haryana
Topic:
Schizophrenia, Psychiatric Rehabilitation
Document Type:
Research Article
Organization / Institution:
Institute of Mental Health, Pt. B.D. Sharma University of Health Sciences, PGIMS
Author:
Dr. Aakanksha Kharb, Dr. Nandini Lamba, Dr. Pradeep Kumar
Target Audience:
Mental Health Professionals, Researchers, Medical Students
Period of Action:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Version:
2.1
Executive Lead:
Executive Director of Quality and Medical Leadership
Lead Author:
Principal Clinical Pharmacist
Approved Date:
14/11/2022
Approved By:
Drugs and Therapeutics Committee (DTC)
Ratified Date:
14/11/2022
Ratified By:
Drugs and Therapeutics Committee (DTC)
Issue Date:
08/02/2023
Expiry Date:
14/11/2025
Target Audience:
Clinical staff
Document Type:
Guidelines
Ratifying Committee:
Drugs and Therapeutics Committee (DTC)
Review Date:
14/11/2025
Summary of significant changes from previous version:
Minor amendments: References to Xeplion® LAI in the document changed to Paliperidone monthly LAI as generic version available
Purpose:
Provide clinical staff with clear guidance on prescribing antipsychotics for the management of psychosis / schizophrenia in adults.
Note:
Year
Theme:
Mental Health / Schizophrenia / Text Messaging
Document Type:
Moderator’s Guide
Author:
Michele
Target Audience:
People with Schizophrenia, Mental Health Professionals
Context:
A moderator’s guide for gathering feedback from individuals with schizophrenia on the effectiveness of text messaging for relapse prevention and symptom monitoring.
Year:
2023
Region / City:
Nanjing, Jiangsu Province, China
Topic:
Neuroscience, Psychiatry, Schizophrenia, Bipolar Disorder
Document Type:
Research Article
Organization / Institution:
Affiliated Brain Hospital of Nanjing Medical University
Author:
Yilin Tang, Ruiqiu Zhu, Yucheng Ling, Yifan Wang, Yingbo Dong, Peiyu Cao, Yuting Li, Qi Si, Guoxin Xu, Zhuma Jin, Yuxiu Sui
Target Audience:
Psychiatry researchers, neuroscientists, medical professionals
Period of Activity:
2023
Date of Approval:
2023
Date of Changes:
Not specified
Keywords:
Schizophrenia, Bipolar disorder, Psychosis symptoms, MRI, Basal ganglia
Abstract:
This study investigates the volume changes of basal ganglia subregions in patients with schizophrenia (SCZ), bipolar disorder (BD), and healthy controls (HC), with a focus on the relationship between these changes and psychotic symptoms.
Species accumulation curve and diversity indices comparison between schizophrenia and control groups
Year:
2026
Region / city:
Not specified
Subject:
Schizophrenia, Metabolomics
Document type:
Research figure and table
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Researchers in schizophrenia and metabolomics
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
Not specified
Region / City:
Not specified
Topic:
Neurological Disorders, Psychiatry, Neuroimaging
Document Type:
Scientific Supplementary Figure
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Researchers, Clinicians
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Contextual Description:
A scientific supplement detailing post-hoc comparisons of FAT and FW between healthy controls, adolescent-onset schizophrenia, and adolescent-onset bipolar disorder with psychosis, using neuroimaging data.
Year:
2023
Region / City:
Global
Topic:
Mental Health, Psychosis, Schizophrenia
Document Type:
Research Protocol / Search Strategy
Organization:
N/A
Author:
N/A
Target Audience:
Researchers, Mental Health Professionals
Effective Period:
N/A
Approval Date:
N/A
Revision Date:
N/A
Keywords:
psychosis, schizophrenia, risk, treatment, early intervention, qualitative research, search strategy
Year:
2001
Region / City:
United States
Theme:
Mental health, biography, film study
Document Type:
Educational assignment / discussion guide
Institution:
High school / college classroom
Author:
Not specified
Target Audience:
Students studying psychology or film
Related Work:
Film "A Beautiful Mind" directed by Ron Howard
Topics Covered:
Schizophrenia, biography, character analysis, treatment methods, critical thinking
Date Assigned:
Not specified
Due Date:
Friday (as mentioned in text)
Year:
2026
Region / City:
Not specified
Subject:
Mental Health / Psychiatry
Document Type:
Clinical Treatment Outline
Institution / Organization:
Not specified
Author:
Not specified
Target Audience:
Mental health professionals
Period of Application:
Initial and ongoing treatment phase
Diagnosis:
F20.9 Schizophrenia
Treatment Goals:
Social, relational, occupational improvement
Assessment Requirements:
Initial clinical assessments as needed
Therapist Characteristics:
Empathy, consistency, reliability
Treatment Location:
Facility-based or therapist’s office depending on patient needs
Interventions:
Role-playing, exposure exercises, individual therapy sessions
Treatment Emphasis:
Interpersonal and occupational skills
Treatment Nature:
Individual therapy, possible family involvement
Frequency and Duration:
Weekly sessions for 6–12 months
Medications:
Antipsychotics as prescribed
Adjunct Services:
Occupational therapy, medical monitoring
Prognosis:
Recovery defined by functional and social improvements; outcome depends on therapeutic relationship and adherence
Note:
Year
Contextual description:
A scientific paper presenting supplementary methods related to polygenic analysis and causal inference in the relationship between loneliness, isolation, and schizophrenia.
Year:
2018
Region / Institution:
National University of Ireland Galway, Ireland
Subject:
Cognitive training, schizophrenia, neuroimaging
Document type:
Systematic review and meta-analysis
Authors:
David Mothersill, Gary Donohoe
Corresponding author:
Gary Donohoe, Professor of Psychology, School of Psychology, National University of Ireland Galway
Number of studies reviewed:
31
Neuroimaging methods:
fMRI, SPECT, PET, cortical thickness, VBM, DTI
Key findings:
Increased left prefrontal activation, distributed neural effects
Keywords:
neuroimaging; cognitive remediation therapy; psychosis; prefrontal
Word count abstract:
225
Word count main text:
3,007
Figures:
2
Tables:
2
Supplemental information:
1
Time period covered:
studies published until December 2018
Year:
2021
Region / city:
United Kingdom
Document Type:
Informational Booklet
Organization / Institution:
British Institute of Human Rights, Equality and Human Rights Commission
Author:
British Institute of Human Rights
Target Audience:
Children and young people under 18
Period of Validity:
Ongoing
Approval Date:
N/A
Amendment Date:
N/A
Year:
1990
Region / City:
Mexico
Topic:
Poetry, Literature, Philosophy
Document Type:
Independent Study
Institution:
N/A
Author:
Octavio Paz
Target Audience:
Students, Literary Scholars
Period of Validity:
N/A
Date of Approval:
N/A
Date of Changes:
N/A
Program Name:
BMORE Beautiful Say YES! Youth Engagement Program
Grant Type:
Youth engagement grant
Deadline:
August 31, 2024
Session:
Fall Session
Program Duration:
September 14 – November 11, 2024
Session Length:
7 weeks
Youth Age Requirement:
14–18
Youth Compensation:
$10 per hour, up to $400 per participant
Maximum Weekly Hours:
5 hours per week
Eligible Applicants:
Neighborhood organizations and non-profits
Application Process:
Competitive
Required Status:
501(c)(3) or fiscal sponsor with 501(c)(3)
Required Documents:
Completed application, 501(c)(3) IRS determination letter, W9 form, fiscal sponsor letter (if applicable)
Reporting Requirements:
Youth perception survey, collection tracking form, timesheets, coordinator invoice
Reporting Deadline:
November 4, 2024
Administering Body:
BMORE Beautiful
Program Liaison:
Brandi Welsh
Contact Email:
[email protected]
Contact Phone:
443-642-0103
Submission Address:
Environmental Control Board, One North Charles St, 13th Floor, Baltimore, MD 21201
Coordinator Compensation:
Up to $250 per enrolled session
Geographic Scope:
Baltimore, MD
Year:
2025
Region / city:
Global
Theme:
Pharmaceutical industry, R&D, patient groups
Document type:
Questionnaire
Organization / institution:
PatientView
Author:
PatientView
Target audience:
Pharmaceutical companies, patient groups
Effective period:
2025-2026
Approval date:
March 30, 2026
Date of changes:
N/A